CN102190661B - 用作抗心律失常剂的三环苯并吡喃化合物 - Google Patents

用作抗心律失常剂的三环苯并吡喃化合物 Download PDF

Info

Publication number
CN102190661B
CN102190661B CN2011100751168A CN201110075116A CN102190661B CN 102190661 B CN102190661 B CN 102190661B CN 2011100751168 A CN2011100751168 A CN 2011100751168A CN 201110075116 A CN201110075116 A CN 201110075116A CN 102190661 B CN102190661 B CN 102190661B
Authority
CN
China
Prior art keywords
amino
carbonyl
dihydro
pyrans
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2011100751168A
Other languages
English (en)
Chinese (zh)
Other versions
CN102190661A (zh
Inventor
生赖一彦
繁田幸宏
上杉理
冈田匠
松田智行
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Publication of CN102190661A publication Critical patent/CN102190661A/zh
Application granted granted Critical
Publication of CN102190661B publication Critical patent/CN102190661B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN2011100751168A 2004-03-23 2005-03-23 用作抗心律失常剂的三环苯并吡喃化合物 Expired - Fee Related CN102190661B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP084605/2004 2004-03-23
JP2004084605 2004-03-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2005800090295A Division CN1934116B (zh) 2004-03-23 2005-03-23 用作抗心律失常剂的三环苯并吡喃化合物

Publications (2)

Publication Number Publication Date
CN102190661A CN102190661A (zh) 2011-09-21
CN102190661B true CN102190661B (zh) 2013-07-31

Family

ID=34962589

Family Applications (3)

Application Number Title Priority Date Filing Date
CN2011100751168A Expired - Fee Related CN102190661B (zh) 2004-03-23 2005-03-23 用作抗心律失常剂的三环苯并吡喃化合物
CN2005800090295A Expired - Lifetime CN1934116B (zh) 2004-03-23 2005-03-23 用作抗心律失常剂的三环苯并吡喃化合物
CN2008101707921A Expired - Fee Related CN101429200B (zh) 2004-03-23 2005-03-23 用作抗心律失常剂的三环苯并吡喃化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN2005800090295A Expired - Lifetime CN1934116B (zh) 2004-03-23 2005-03-23 用作抗心律失常剂的三环苯并吡喃化合物
CN2008101707921A Expired - Fee Related CN101429200B (zh) 2004-03-23 2005-03-23 用作抗心律失常剂的三环苯并吡喃化合物

Country Status (30)

Country Link
US (2) US7652008B2 (cg-RX-API-DMAC7.html)
EP (1) EP1732929B1 (cg-RX-API-DMAC7.html)
JP (1) JP4840594B2 (cg-RX-API-DMAC7.html)
KR (2) KR101019402B1 (cg-RX-API-DMAC7.html)
CN (3) CN102190661B (cg-RX-API-DMAC7.html)
AT (1) ATE485299T1 (cg-RX-API-DMAC7.html)
AU (2) AU2005223612B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0508768A (cg-RX-API-DMAC7.html)
CA (1) CA2558139C (cg-RX-API-DMAC7.html)
CY (1) CY1111250T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ2006598A3 (cg-RX-API-DMAC7.html)
DE (1) DE602005024245D1 (cg-RX-API-DMAC7.html)
DK (1) DK1732929T3 (cg-RX-API-DMAC7.html)
EG (1) EG27163A (cg-RX-API-DMAC7.html)
ES (1) ES2353021T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20110005T1 (cg-RX-API-DMAC7.html)
IL (1) IL177950A (cg-RX-API-DMAC7.html)
MX (1) MXPA06010880A (cg-RX-API-DMAC7.html)
NO (1) NO339495B1 (cg-RX-API-DMAC7.html)
NZ (2) NZ549570A (cg-RX-API-DMAC7.html)
PL (1) PL1732929T3 (cg-RX-API-DMAC7.html)
PT (1) PT1732929E (cg-RX-API-DMAC7.html)
RS (1) RS51742B (cg-RX-API-DMAC7.html)
RU (1) RU2380370C2 (cg-RX-API-DMAC7.html)
SI (1) SI1732929T1 (cg-RX-API-DMAC7.html)
SK (1) SK287994B6 (cg-RX-API-DMAC7.html)
TW (1) TWI352704B (cg-RX-API-DMAC7.html)
UA (1) UA91189C2 (cg-RX-API-DMAC7.html)
WO (1) WO2005090357A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200607388B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4840594B2 (ja) * 2004-03-23 2011-12-21 日産化学工業株式会社 抗不整脈薬としての3環性ベンゾピラン化合物
US8394974B2 (en) 2006-03-10 2013-03-12 Nissan Chemical Industries, Ltd. Process for producing optically active chromene oxide compound
WO2010018867A1 (ja) * 2008-08-14 2010-02-18 日産化学工業株式会社 ジ置換ベンゾピラン化合物
AR076524A1 (es) * 2009-04-30 2011-06-15 Nissan Chemical Ind Ltd Forma cristalina de un compuesto de benzopirano triciclico y metodo de produccion de la misma
PT2445502T (pt) 2009-06-25 2017-09-22 Alkermes Pharma Ireland Ltd Compostos heterocíclicos para o tratamento de distúrbios neurológicos e psicológicos
US9738654B2 (en) 2012-09-27 2017-08-22 Nissan Chemical Industries, Ltd. Method for producing nitrogen-containing heterocyclic N-oxide compound
CN104507949B (zh) * 2012-09-27 2017-07-28 日产化学工业株式会社 高纯度的含氮杂环化合物的制造方法
CN105377826A (zh) * 2013-07-25 2016-03-02 日产化学工业株式会社 杂环化合物的制造方法
CN110177796B (zh) * 2017-01-06 2022-04-08 阿斯克里斯有限公司 喹啉酮衍生物及其用于预防或治疗变应性疾病的药物组合物
AU2019230014B2 (en) 2018-03-05 2024-11-28 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN108727261B (zh) * 2018-06-21 2021-09-24 济南大学 一种硝基取代喹那啶的制备方法
CN113543849B (zh) * 2018-12-28 2025-03-21 国立大学法人大阪大学 遗传性缓慢性心律失常治疗药
RU2754610C1 (ru) * 2020-04-14 2021-09-03 Георгий Викторович ТЕЦ Препарат для лечения заболеваний, вызванных бактериями
JP7733887B2 (ja) * 2020-06-26 2025-09-04 国立大学法人大阪大学 薬剤誘発性徐脈および徐脈性不整脈治療薬

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0327127A1 (en) * 1988-02-03 1989-08-09 Nissan Chemical Industries Ltd. Pyranobenzoxadiazole derivatives, preparation, use and compositions comprising them
EP0409165A2 (en) * 1989-07-17 1991-01-23 Nissan Chemical Industries Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
EP0488107A2 (en) * 1990-11-26 1992-06-03 E.R. SQUIBB & SONS, INC. Tricyclic benzodiazole analogs and their use in the treatment of cardiovascular disorders
WO1995034547A1 (en) * 1994-06-10 1995-12-21 Smithkline Beecham Plc C-4 amide substituted compounds and their use as therapeutic agents

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM7682A1 (en) 1981-09-25 1983-05-23 Beecham Group Plc Active compounds
JPS5867683U (ja) 1981-10-28 1983-05-09 株式会社ナムコ 歩行ロボツト
JP2658198B2 (ja) * 1988-06-23 1997-09-30 日産化学工業株式会社 ピラノベンゾトリアゾール誘導体
JP2876712B2 (ja) * 1989-07-17 1999-03-31 日産化学工業株式会社 光学活性ピラノベンゾオキサジアゾール誘導体
EP0693283A4 (en) 1993-04-02 1997-07-23 Nissan Chemical Ind Ltd REMEDY FOR HEART FAILURE
JPH07300414A (ja) * 1993-04-02 1995-11-14 Nissan Chem Ind Ltd 心不全治療薬
JP2734457B2 (ja) 1994-02-23 1998-03-30 日産化学工業株式会社 不斉エポキシ化反応
TW496866B (en) * 1996-05-15 2002-08-01 Hoechst Ag Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or a diagnostic, and medicament comprising them
WO1999062867A1 (fr) 1998-06-03 1999-12-09 Nissan Chemical Industries, Ltd. Derives d'indane
AU5444499A (en) 1998-09-01 2000-03-21 Nissan Chemical Industries Ltd. Benzoxazine derivatives
AU2830800A (en) 1999-03-25 2000-10-16 Nissan Chemical Industries Ltd. Chroman derivatives
WO2001021610A1 (en) 1999-09-17 2001-03-29 Nissan Chemical Industries, Ltd. Benzopyran derivative
US6555574B1 (en) 1999-09-24 2003-04-29 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
US6677371B1 (en) 1999-10-05 2004-01-13 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
IL159218A0 (en) 2001-06-25 2004-06-01 Nissan Chemical Ind Ltd Substituted benzopyran derivatives against arrhythmia
WO2003014113A1 (en) 2001-08-06 2003-02-20 Glenmark Pharmaceuticals Limited Novel benzopyran compounds and process for their preparation and use
JP4840594B2 (ja) * 2004-03-23 2011-12-21 日産化学工業株式会社 抗不整脈薬としての3環性ベンゾピラン化合物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0327127A1 (en) * 1988-02-03 1989-08-09 Nissan Chemical Industries Ltd. Pyranobenzoxadiazole derivatives, preparation, use and compositions comprising them
EP0409165A2 (en) * 1989-07-17 1991-01-23 Nissan Chemical Industries Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
EP0488107A2 (en) * 1990-11-26 1992-06-03 E.R. SQUIBB & SONS, INC. Tricyclic benzodiazole analogs and their use in the treatment of cardiovascular disorders
WO1995034547A1 (en) * 1994-06-10 1995-12-21 Smithkline Beecham Plc C-4 amide substituted compounds and their use as therapeutic agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Wai N.Chan,et al.,.Conformational preference of the 6-acetyl group in novel anticonvulsant trans 4S-benzamido-benzo[b]pyran-3R-ols.《Bioorganic & Medicinal Chemistry Letters》.1997,第7卷(第12期),1573-1576. *

Also Published As

Publication number Publication date
DK1732929T3 (da) 2010-12-20
US20100069374A1 (en) 2010-03-18
NZ585606A (en) 2011-11-25
UA91189C2 (en) 2010-07-12
SK287994B6 (sk) 2012-09-03
PT1732929E (pt) 2010-12-21
CA2558139C (en) 2012-01-17
NZ549570A (en) 2010-08-27
HRP20110005T1 (hr) 2011-02-28
WO2005090357A1 (en) 2005-09-29
US7964623B2 (en) 2011-06-21
CN1934116B (zh) 2012-10-10
TW200600509A (en) 2006-01-01
ATE485299T1 (de) 2010-11-15
SK50792006A3 (sk) 2007-09-06
RS51742B (sr) 2011-10-31
KR101019402B1 (ko) 2011-03-07
KR20100130249A (ko) 2010-12-10
AU2010202900B2 (en) 2011-10-27
AU2005223612A1 (en) 2005-09-29
IL177950A (en) 2013-04-30
AU2005223612B2 (en) 2010-06-24
KR101085979B1 (ko) 2011-11-22
BRPI0508768A (pt) 2007-02-27
MXPA06010880A (es) 2006-12-15
KR20070009638A (ko) 2007-01-18
CN101429200B (zh) 2012-05-30
NO339495B1 (no) 2016-12-19
CY1111250T1 (el) 2015-06-11
JP2007530436A (ja) 2007-11-01
SI1732929T1 (sl) 2010-12-31
NO20064819L (no) 2006-10-23
EP1732929B1 (en) 2010-10-20
ES2353021T3 (es) 2011-02-24
AU2010202900A1 (en) 2010-07-29
CA2558139A1 (en) 2005-09-29
EP1732929A1 (en) 2006-12-20
CN1934116A (zh) 2007-03-21
IL177950A0 (en) 2006-12-31
EG27163A (en) 2015-08-24
JP4840594B2 (ja) 2011-12-21
PL1732929T3 (pl) 2011-04-29
DE602005024245D1 (de) 2010-12-02
CZ2006598A3 (cs) 2006-11-15
RU2006137284A (ru) 2008-04-27
US7652008B2 (en) 2010-01-26
HK1099299A1 (en) 2007-08-10
TWI352704B (en) 2011-11-21
CN102190661A (zh) 2011-09-21
CN101429200A (zh) 2009-05-13
US20080004262A1 (en) 2008-01-03
RU2380370C2 (ru) 2010-01-27
ZA200607388B (en) 2008-07-30

Similar Documents

Publication Publication Date Title
AU2010202900B2 (en) Tricyclic benzopyran compound as anti-arrhythmic agents
JP5940562B2 (ja) イオンチャネルのモジュレーターとしてのクロマン−スピロ環式ピペリジンアミド
CA2917198C (en) Fused piperidine amides as modulators of ion channels
WO2002074769A1 (en) Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient
ES2887087T3 (es) Sulfonas tricíclicas como moduladores ROR gamma
CN115667226B (zh) 作为egfr抑制剂的三环化合物
CN108467369A (zh) 作为激酶抑制剂的联芳基酰胺化合物
KR20200136958A (ko) 공유 메닌 억제제로서의 피페리딘 화합물
CN106459033B (zh) 作为间变性淋巴瘤酶(alk)抑制剂的吲哚并喹诺酮类化合物
CN103180312B (zh) 用于治疗或预防因血清素、去甲肾上腺素或多巴胺的神经传导的降低所导致的紊乱的杂环化合物
WO2025247396A1 (zh) 杂环类衍生物及其制备方法和用途
HK1099299B (en) Tricyclic benzopyran compound as anti-arrhythmic agents
HK40077537A (en) Substituted tricyclic amides, analogues thereof, and methods using same
HK40008995A (en) Substituted carbonucleoside derivatives useful as anticancer agents
MXPA06013392A (en) Substituted azepine derivatives as serotonin receptor modulators

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: Tokyo, Japan

Patentee after: NISSAN CHEMICAL INDUSTRIES, Ltd.

Address before: Tokyo, Japan

Patentee before: NISSAN CHEMICAL INDUSTRIES, Ltd.

CP01 Change in the name or title of a patent holder
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130731

CF01 Termination of patent right due to non-payment of annual fee